Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 2141-2146

  Schneider, José ^a,d   Jiménez, Elisa ^a   Marenbach, Katrin ^a,b   Romero, Hernando ^a,c   Marx, Dagmar ^b   Meden, Harald ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c UNIVERSIDAD DEL CAUCA   (Colombia)

^d Centro de Patologia de la Mama   (Spain)

Author keywords

HSP60; Ovarian cancer; Prognosis; Survival

Indexed keywords

BIOTIN; HEAT SHOCK PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PARAFFIN; PEROXIDASE; STREPTAVIDIN;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING;

ANTIBODIES, MONOCLONAL; CARCINOMA; CHAPERONIN 60; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LIFE TABLES; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0344631749     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lindquist S, Craig EA: The heat-shock proteins. Ann Rev Genet 22:631-677, 1988.
2. Fuller KJ, Issels RD, Slosman DO, et al: Cancer and the heat shock response. Eur J Cancer 30A: 1884-1891, 1994.
3. Brodsky JL: Post-translational protein translocation: not all hsc70s are created equal. TIBS 21: 122-126, 1996.
4. Kimura E, Enns RE, Alcaraz JE, et al: Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. J Clin Oncol 11: 891 -898, 1993.
5. Schneider J, Moragues D, Martinez N, et al: Cross reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies, PA1 OF and C6. Br J Cancer 77: 1015-1020, 1998.
6. Schneider J, Romero H, Ruiz R et al: nm23 expression in advanced and borderline ovarian carcinoma. Anticancer Res 16: 1197-1202, 1996.
7. Agard DA: To fold or not to fold. Science 260: 1903-1904, 1993.
8. Georgopoulos C, Welch WJ: Role of the major het shock proteins as molecular chaperones. Annu Rev Cell Biol 9: 601-634, 1993.
9. Kimura E, HowellSB: Regulation of the expression of heat shock protein 60 (HSP-60) mRNA in a human ovarian carcinoma cell line. Proc Am Assoc Cancer Res 32: 362 (abstr), 1991.
10. Enns RE, Hom D, Thiebaut F, et al: An amplified mitochondrial chaperonin gene causes resistance to cisplatin in human ovarian tumor cells. Proc Am Assoc Cancer Res 32: 353 (abstr), 1991.